Home/Filings/4/0001415889-25-009687
4//SEC Filing

Stewart Jeffrey Ryan 4

Accession 0001415889-25-009687

CIK 0001551152other

Filed

Apr 1, 8:00 PM ET

Accepted

Apr 2, 5:00 PM ET

Size

11.8 KB

Accession

0001415889-25-009687

Insider Transaction Report

Form 4
Period: 2025-03-31
Stewart Jeffrey Ryan
EVP, CHIEF COMMERCIAL OFFICER
Transactions
  • Sale

    Common Stock, $0.01 par value

    2025-03-31$209.49/sh25,700$5,383,89386,366 total
  • Sale

    Common Stock, $0.01 par value

    2025-03-31$210.54/sh33,132$6,975,61153,234 total
  • Exercise/Conversion

    Option (Right to Buy)

    2025-03-31$79.02/sh25,700$2,030,8140 total
    Exercise: $79.02Exp: 2029-02-20Common Stock (25,700 underlying)
  • Exercise/Conversion

    Common Stock, $0.01 par value

    2025-03-31$79.02/sh+25,700$2,030,814112,066 total
Holdings
  • Common Stock, $0.01 par value

    (indirect: By Trust)
    1,338
Footnotes (4)
  • [F1]The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $209.43 to $209.60, inclusive. The reporting person undertakes to provide AbbVie Inc., any security holder of AbbVie Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F2]The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $210.54 to $210.63, inclusive. The reporting person undertakes to provide AbbVie Inc., any security holder of AbbVie Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F3]The reporting person disclaims beneficial ownership of all securities held by his spouse.
  • [F4]Employee stock option granted pursuant to the AbbVie Amended and Restated 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.

Issuer

AbbVie Inc.

CIK 0001551152

Entity typeother

Related Parties

1
  • filerCIK 0001761675

Filing Metadata

Form type
4
Filed
Apr 1, 8:00 PM ET
Accepted
Apr 2, 5:00 PM ET
Size
11.8 KB